We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

241 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 103 increasing their positions, 37 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 37

126% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 27

37% more capital invested

Capital invested by funds: $239M → $328M (+$88.5M)

15% more funds holding

Funds holding: 210 → 241 (+31)

4.74% more ownership

Funds ownership: 9.33% → 14.07% (+4.7%)

3% less call options, than puts

Call options by funds: $11.9M | Put options by funds: $12.2M

Holders
241
Holders Change
+31
Holders Change %
+14.76%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
61
Increased
103
Reduced
37
Closed
27
Calls
$11.9M
Puts
$12.2M
Net Calls
-$313K
Net Calls Change
+$5.37M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$22.1M
2
AC
Armistice Capital
New York
+$20.9M
3
Jane Street
Jane Street
New York
+$20.4M
4
BlackRock
BlackRock
New York
+$12M
5
AC
AlphaCore Capital
California
+$8M

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$1.56M
2
Group One Trading
Group One Trading
Illinois
-$1.53M
3
HF
HRT Financial
New York
-$715K
4
UBS Group
UBS Group
Switzerland
-$666K
5
Citigroup
Citigroup
New York
-$612K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
201
Sterling Capital Management
North Carolina
$3.76K +$1.96K +730 +105%
Jones Financial Companies
202
Jones Financial Companies
Missouri
$3.51K -$45.9K -17,086 -93%
BL
203
BFSG LLC
California
$3.43K – – –
AW
204
Avion Wealth
Texas
$3K +$949 +353 +41%
OP
205
ORG Partners
Indiana
$2.96K +$3.09K +1,150 New
S
206
SignatureFD
Georgia
$2.78K +$2.07K +770 +273%
EWA
207
EverSource Wealth Advisors
Alabama
$2.67K +$116 +43 +4%
CTC
208
Central Trust Company
Missouri
$2.64K – – –
HI
209
Harbour Investments
Wisconsin
$2.64K +$2.69K +1,000 New
MIM
210
MTM Investment Management
South Carolina
$2.64K +$2.69K +1,000 New
AF
211
Allworth Financial
California
$2.36K +$2.12K +788 +750%
GWM
212
Geneos Wealth Management
Colorado
$2.24K -$2.28K -847 -50%
AUB
213
Atlantic Union Bankshares
Virginia
$2.02K +$2.05K +764 New
BFP
214
Briaud Financial Planning
Texas
$2K +$2.69K +1,000 New
RIL
215
Rothschild Investment LLC
Illinois
$1.99K +$914 +340 +82%
AAP
216
Arax Advisory Partners
Colorado
$1.58K – – –
TCM
217
Tradewinds Capital Management
Washington
$1.32K – – –
MAWAG
218
Mid-American Wealth Advisory Group
Missouri
$1.23K +$1.25K +465 New
Optiver Holding
219
Optiver Holding
Netherlands
$1.2K +$1.22K +454 New
IA
220
IFP Advisors
Florida
$1.16K +$1.18K +439 New
CTA
221
Colonial Trust Advisors
South Carolina
$1.12K – – –
SWM
222
Spire Wealth Management
Virginia
$1.11K – – –
NA
223
NewEdge Advisors
Louisiana
$924 -$3 -1 -0.3%
MCM
224
MAI Capital Management
Ohio
$919 – – –
ATC
225
Adirondack Trust Company
New York
$394 – – –
7 8
9
10 11

IBRX Hedge Fund Activity: Q2 2025 in Review

241 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2025, worth a combined $328M — up 37% from $239M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new IBRX positions and 27 closed out — a net gain of 34 holders — while 103 added to existing stakes and 37 trimmed.

The largest buyer was Bank of America, adding an estimated $22.1M. The largest seller was Verition Fund Management, cutting an estimated $1.56M.

  • 241 institutional investors held ImmunityBio (IBRX) as of Q2 2025, up from 210 in Q1 2025.
  • Funds reported $328M of ImmunityBio stock for Q2 2025, up 37% quarter-over-quarter.
  • 61 funds opened new ImmunityBio positions in Q2 2025 and 27 closed out, a net change of +34 holders.
  • The largest ImmunityBio buyer in Q2 2025 was Bank of America, an estimated $22.1M added.
  • The largest ImmunityBio seller in Q2 2025 was Verition Fund Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q2 2025.